Characterization of protein components of human urinary crystal surface binding substance

Urological Research

Volumn 25, Issue 5, 1997, Pages 355-360

  Honda, M ^a   Yoshioka, T ^a   Yamaguchi, S ^a   Yoshimura, K ^a   Miyake, O ^a   Utsunomiya, M ^a   Koide, T ^a   Okuyama, A ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Calcium oxalate; Crystal surface binding substance; Crystallization; Osteopontin; Protein inhibitor; Prothrombin

Indexed keywords

ALPHA 1 MICROGLOBULIN; CALCIUM OXALATE; OROSOMUCOID; OSTEOPONTIN; PROTEIN; PROTEIN INHIBITOR; PROTHROMBIN; RETINOL BINDING PROTEIN; SERUM ALBUMIN; TAMM HORSFALL GLYCOPROTEIN; TRANSFERRIN;

ARTICLE; CRYSTALLIZATION; HUMAN; MALE; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; STONE FORMATION; UROLITHIASIS;

ADULT; AMINO ACID SEQUENCE; CALCIUM OXALATE; CHROMATOGRAPHY; CRYSTALLIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GLYCOPROTEINS; HUMANS; MALE; OSTEOPONTIN; PROTHROMBIN; SIALOGLYCOPROTEINS;

EID: 0030733045     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01294665     Document Type: Article

References (20)

1. Atimani F, Lacour B, Drueke T, Daudon M (1993) Isolation and purification of new glycoprotein from human urine inhibiting calcium oxalate crystallization Urol Res 21:61
2. Atmani F, Khan SR (1995) Characterization of uronic-acidrich inhibitor of calcium oxalate crystallization isolated from rat urine. Urol Res 23:95
3. Burnette WN (1981) "Western blotting": electrophoretic transfer of proteins from sodium dodecylsulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 112:195
4. Degen SJF, MacGilivray RTA, Davie EW (1983) Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin Biochemistry 22:2087
5. Doyle IR, Ryall RL, Marshall VR (1991) Inclusion of proteins into calcium oxalate crystals precipitated from human urine: a highly selective phenomenon. Clin Chem 37:1589
6. Dussol B, Geider S, Lilova A, Leonetti F, Dupuy P, Daudon M, Berland Y, Dagorn JC, Verdier JM (1995) Analysis of the soluble organic matrix of five morphologically different kidney stones. Evidence for a specific role of albumin in the constitution of the stone matrix protein. Urol Res 23:45
7. Fandale RW, Sayers CA, Barret AJ (1982) A direct spectrophotometer microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 9:247
8. Ferix R, Monod A, Broge L, Hansen NM, Fleisch H (1977) Aggregation of calcium oxalate crystals: effect of urine and various inhibitors. Urol Res 5:21
9. Gill WB, Karesh JW, Garsin L, Roma MJ (1977) Inhibitory effect of urinary macromolecules on the crystallization of calcium oxalate. Invest Urol 15:95
10. Kohri K, Suzuki Y, Yoshida K, Yamamoto K, Amasaki N, Yamate T, Umekawa T, Iguchi M, Shinohara H, Kurita T (1992) Molecular cloning and sequencing of cDNA encoding urinary stone protein. which is identical to osteopontin. Biochem Biophys Res Commun 184:859
11. Koide T, Takemoto M, Itatani H, Takaha M, Sonoda T (1981) Urinary macromolecular substances as natural inhibitors of calcium oxalate crystal aggregation. Invest Urol 18 382
12. Koide T, Yoshioka T, Yamaguchi S, Hosokawa S, Utsunomiya M, Sonoda T (1990) Urinary crystal surface binding substances on calcium oxalate crystals. Urol Res 18:387
13. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265
14. Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. Inhibition by natural urinary crystal growth inhibition. Invest Urol 13:36
15. Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe FL (1983) Purification and characterization of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:594
16. Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. Clin Chim Acta 43:31
17. Shiraga H, Min W, Van Ducen WJ, Clayman MD, Miner D, Terrel CH, Sherboite JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin. another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426
18. Suzuki K, Moriyama M, Nakajima C, Kawamura K, Miyazawa K, Tsugawa R, Kikuchi N, Nagata K (1994) Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin. Urol Res 22:45
19. Umekawa T, Yamate T, Amasaki N, Kohri K, Kurita T (1995) Osteopontin mRNA in the kidney in an experimental rat model of renal stone formation without renal failure. Urol Int 55:6
20. Yamaguchi S, Yoshioka T, Utsunomiya M, Koide T, Osafune M, Okuyama A, Sonada T (1993) Heparan sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization. Urol Res 21:187